Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company focused on oncology treatments, dedicated to developing novel antibody therapies targeting tumor-specific antigens. Since its establishment in late 2021, SolveTx has been actively conducting discovery and development work in its state-of-the-art laboratory facilities located in San Diego, California, and Durham, North Carolina. The company has licensed or generated targeted antibodies and nanobodies with desirable characteristics as the backbone for antibody-based therapies and holds rights to technologies supporting the development of diagnostic and therapeutic antibody-radionuclide conjugates (ARCs).